Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep;259(9):2521-2531.
doi: 10.1007/s00417-021-05113-3. Epub 2021 Mar 6.

Functional recovery after macula involving retinal detachment and its correlation with preoperative biomarkers in optical coherence tomography

Affiliations

Functional recovery after macula involving retinal detachment and its correlation with preoperative biomarkers in optical coherence tomography

Julian E Klaas et al. Graefes Arch Clin Exp Ophthalmol. 2021 Sep.

Abstract

To introduce an ETDRS grid-based classification for macula involving retinal detachment (MIRD) with or without center (foveal) involvement and to identify biomarkers in preoperative optical coherence tomography (OCT) associated with a favorable postoperative functional outcome in eyes with center involving retinal detachment (CIRD). One hundred and two eyes of 102 consecutive patients (f/m: 35/67) with primary rhegmatogenous retinal detachment, preoperative evidence of MIRD (perifoveal involvement of ≤ 6.0 mm), and successful retinal surgery were included in this retrospective cohort study. Eyes were assigned to 5 grades of MIRD (G1-G5), based on the extent of detachment in the ETDRS grid. Eyes with a detached foveal status (CIRD) were assigned to G4 or G5. In CIRD, the following OCT biomarkers were quantified and correlated with mean BCVA (logMAR) at 3 months postsurgery, using univariate and multivariable regression models: grade of detachment, extent of intraretinal edema, height of foveal detachment, subretinal folds, and epiretinal membrane. Forty-one of 102 eyes (40.2%) presented with an attached foveal status, defined as either outer (G1: 11.8%) or inner (G2: 18.6%) macular involvement or fovea-threatening MIRD (G3: 9.8%). Sixty-one eyes (59.8%) showed CIRD (G4 or G5). Eyes with CIRD had significantly worse postoperative BCVA than eyes without foveal involvement (0.355 logMAR vs. 0.138 logMAR, p<0.001). If CIRD was limited to three outer ETDRS quadrants (G4), mean BCVA was better compared to CIRD involving all four ETDRS quadrants (G5) (0.254 logMAR vs. 0.522 logMAR, p<0.001). Reading ability (BCVA ≤ 0.4 logMAR) was restored in 97.6% of eyes with G1-G3 compared to 86.9% of eyes with G4 (p=0.072) and 52.4% of eyes with G5 (p<0.001). In multivariable regression analysis of eyes with CIRD, a lower grade of detachment (G4 vs. G5: p<0.05) and lower extent of cystoid edema (focal/none vs. wide: p<0.001) were both associated with better postoperative function. The functional outcome after MIRD may be worse in the presence of foveal involvement (CIRD), but a lower grade of detachment and the absence of intraretinal edema can predict a good recovery in spite of CIRD.

Keywords: Biomarker; CIRD; Center Involving Retinal; Detachment; Fovea-off; MIRD; Macula Involving Retinal Detachment; Macula-off; Macula-on; Morphology; Nomenclature; OCT; Optical coherence tomography; Retinal detachment; Rhegmatogenous.

PubMed Disclaimer

Conflict of interest statement

J Klaas reports personal fees from Novartis, outside of the submitted work. N Feucht reports personal fees from Novartis, Allergan, Bayer, and Heidelberg Engineering, outside the submitted work. J Siedlecki received previous speaker fees and travel expenses from Novartis Pharma GmbH, Carl Zeiss Meditec AG, Oculentis OSD Medical GmbH, and Pharm-Allergan GmbH. Jakob Siedlecki received personal consultation fees from Novartis Pharma GmbH, Bayer AG, and Pharm-Allergan GmbH. Jakob Siedlecki received travel support from Oertli AG. M Maier reports speaker honoraria from Novartis, Allergan, Bayer, Heidelberg Engineering, and Zeiss, Clinical Trials (Bayer, Novartis, Roche), outside the submitted work. P Rechl, J Friedrich, and CP Lohmann have nothing to disclose.

Figures

Fig. 1
Fig. 1
Flow chart depicting process of data acquisition and eligibility criteria for in- and exclusion of patients resulting in a retrospective cohort of 102 eyes of 102 patients with primary rhegmatogenous macula involving retinal detachment (MIRD)
Fig. 2
Fig. 2
Illustration for 5 grades of macula involving retinal detachment (MIRD) based on the morphological extent of involvement using the ETDRS grid in optical coherence tomography (OCT)
Fig. 3
Fig. 3
Infrared-image (IR) with ETRDS grid and SD-OCT (30°) of 6 eyes, representing 5 grades of macula involving retinal detachment (MIRD). a–c represent MIRD without center involvement (G1–G3). d CIRD with limited macular detachment (G4): ∂ marks one outer macular quadrant where no subretinal fluid can be detected in volume or radial scans. e, f show detachment involving all 4 outer macular quadrants (marked with ∂) defined as G5 (“CIRD with complete macular detachment“). Dotted white circles in a–c indicate subretinal fluid within this circle. A drawn through white circle indicates that subretinal fluid does not cross this boundary. White and black arrows mark margin of detachment correlating to localization in IR/OCT scans; ƒ in d represents height of foveal detachment (FDH = 291 μm, measured perpendicularly to RPE in 1:1 resolution); * marks focal (e) and wide (f) cystoid intraretinal edema with a perifoveal radius of ≤ 3.0 mm (black dotted circle/lines) serving as cutoff

References

    1. Klaas JE, Rechl P, Klein J, Feucht N, Lohmann CP, Maier M (2020) OCT Biomarker bei rhegmatogener Netzhautablösung mit Makulabeteiligung. Deutsche Ophthalmologische Gesellschaft. 10.1007/s00347-020-01298-w
    1. Hakin KN, Lavin MJ, Leaver PK. Primary vitrectomy for rhegmatogenous retinal detachment. Graefes Arch Clin Exp Ophthalmol. 1993;231(6):344–346. doi: 10.1007/bf00919031. - DOI - PubMed
    1. Ross WH, Stockl FA. Visual recovery after retinal detachment. Curr Opin Ophthalmol. 2000;11(3):191–194. doi: 10.1097/00055735-200006000-00007. - DOI - PubMed
    1. Salicone A, Smiddy WE, Venkatraman A, Feuer W. Visual recovery after scleral buckling procedure for retinal detachment. Ophthalmology. 2006;113(10):1734–1742. doi: 10.1016/j.ophtha.2006.03.064. - DOI - PubMed
    1. Mendrinos E, Dang-Burgener NP, Stangos AN, Sommerhalder J, Pournaras CJ. Primary vitrectomy without scleral buckling for pseudophakic rhegmatogenous retinal detachment. Am J Ophthalmol. 2008;145(6):1063–1070. doi: 10.1016/j.ajo.2008.01.018. - DOI - PubMed

LinkOut - more resources